Suchergebnisse - "Su, Yongwei"

PubPharm (4)

1

The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML

enthalten in: Blood cancer journal | 2021

von Qiao, X. | Ma, J. | Knight, T. | +14

2

The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia

enthalten in: Haematologica | 2021

von Li, X. | Su, Y. | Hege, K. | +15

3

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia

enthalten in: Haematologica | 2019

von Li, X. | Su, Y. | Madlambayan, G. | +13

4

Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells

enthalten in: Scientific reports | 2017

von Ma, J. | Li, X. | Su, Y. | +11

1
[1]